IP Verse

Alpha-Amylase Conbinatorial Variants

EP3336183

DANISCO US INC.
Application Number
EP18151284A
Filing Date
Mar 11, 2014
Status
Granted And Under Opposition
Apr 9, 2021
Grant Date
May 12, 2021
External Links
Slate, Register

Biblio Summary

The patent EP3336183B1 was granted on May 12, 2021 by Danisco Us Inc. The patent is currently Granted And Under Opposition.

Oppositions Filed by other Companies on the Patent

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

NOVOZYMES A/SFeb 10, 2022ADMISSIBLE

More Opposed Patents of Danisco Us Inc.

The table below shows the patents of Danisco Us Inc. that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP2215202Variants Of Bacillus Sp. Ts-23 Alpha-Amylase With Altered PropertiesJan 10, 20241
EP2268804Hemicellulase Enriched Compositions For Enhancing Hydrolysis Of BiomassAug 9, 20231
EP2859097Alpha-Amylase Variants Derived From The Alpha Amylase Of Cytophaga Sp.Amylase (Cspamy2).Mar 8, 20231

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.

  • Date

    Description

  • Get instant alerts for new documents